β-Casein hydrolysate generated by the cell envelope-associated proteinase of Lactobacillus delbrueckii ssp. lactis CRL 581 protects against trinitrobenzene sulfonic acid-induced colitis in mice

Journal of Dairy Science

Volumn 95, Issue 3, 2012, Pages 1108-1118

  Espeche Turbay, M B ^a   De Moreno de LeBlanc, A ^a   Perdigon G ^a   Savoy de Giori, G ^a   Hebert, E M ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

Bioactive peptide; Casein hydrolysate; Lactic acid bacteria; Proteinase

Indexed keywords

ANTIMUTAGENIC AGENT; BETA GLUCURONIDASE; CASEIN; PEROXIDASE; PROTEIN HYDROLYSATE; TRINITROBENZENESULFONIC ACID;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; COLITIS; DISEASE MODEL; FEMALE; LACTOBACILLUS DELBRUECKII; METABOLISM; MOUSE; MUTAGEN TESTING;

ANIMALS; ANTIMUTAGENIC AGENTS; CASEINS; COLITIS; DISEASE MODELS, ANIMAL; FEMALE; GLUCURONIDASE; LACTOBACILLUS DELBRUECKII; MICE; MICE, INBRED BALB C; MUTAGENICITY TESTS; PEROXIDASE; PROTEIN HYDROLYSATES; TRINITROBENZENESULFONIC ACID;

EID: 84857332034     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2011-4735     Document Type: Article

References (35)

1. Ameho C.K., Adjei A.A., Harrison E.K., Takeshita K., Morioka T., Arakaki Y., Ito E., Suzuki I., Kulkarni A.D., Kawajiri A., Yamamoto S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41:487-493.
2. Bradley P.P., Christensen R.D., Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 1982, 60:618-622.
3. Chandran P., Satthaporn S., Robins A., Eremin O. Inflammatory bowel disease: Dysfunction of GALT and gut bacterial flora (I). Surgeon 2003, 1:63-75.
4. Chaves S., Perdigon G., de Moreno de LeBlanc A. Yoghurt consumption regulates the immune cells implicated in acute intestinal inflammation and prevents the recurrence of the inflammatory process in a mouse model. J. Food Prot. 2011, 74:801-811.
5. de Moreno de LeBlanc A., Chaves S., Perdigón G. Effect of yoghurt on the cytokine profile using a murine model of intestinal inflammation. Eur. J. Inflamm. 2009, 7:97-109.
6. de Moreno de LeBlanc A., Matar C., Perdigón G. The application of probiotics in cancer. Br. J. Nutr. 2007, 98:S105-S110.
7. Espeche Turbay M.B., Savoy de Giori G., Hebert E.M. Release of the cell-envelope-associated proteinase of Lactobacillus delbrueckii subspecies lactis CRL 581 is dependent upon pH and temperature. J. Agric. Food Chem. 2009, 57:8607-8611.
8. Goldin B.R., Swenson L., Dwyer J., Sexton M., Gorbach S.L. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J. Natl. Cancer Inst. 1980, 64:255-261.
9. Hayes M., Ross R.P., Fitzgerald G.F., Stanton C. Putting microbes to work: Dairy fermentation, cell factories and bioactive peptides. Part I: Overview. Biotechnol. J. 2007, 2:426-434.
10. s1- and β-casein breakdown and release of a bioactive peptide by a cell envelope proteinase from Lactobacillus delbrueckii subsp. lactis CRL 581. Appl. Environ. Microbiol. 2008, 74:3682-3689.
11. Hébert E.M., Raya R., Savoy de Giori G. Use of SDS-PAGE of cell-wall proteins for rapid differentiation of Lactobacillus delbrueckii ssp. lactis and Lactobacillus helveticus. Biotechnol. Lett. 2000, 22:1003-1006.
12. Hebert E.M., Raya R.R., De Giori G.S. Nutritional requirements and nitrogen-dependent regulation of proteinase activity of Lactobacillus helveticus CRL 1062. Appl. Environ. Microbiol. 2000, 66:5316-5321.
13. Hébert E.M., Raya R.R., de Giori G.S. Modulation of the cell-surface proteinase activity of thermophilic lactobacilli by the peptide supply. Curr. Microbiol. 2002, 45:385-389.
14. Hebert E.M., Saavedra L., Ferranti P. Bioactive peptides derived from casein and whey proteins. Biotechnology of Lactic Acid Bacteria: Novel Applications 2010, 233-249. Wiley-Blackwell, Ames, IA. F. Mozzi, R. Raya, G. Vignolo (Eds.).
15. Hsieh M.L., Chou C.C. Mutagenicity and antimutagenic effect of soymilk fermented with lactic acid bacteria and bifidobacteria. Int. J. Food Microbiol. 2006, 111:43-47.
16. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 2009, 27:313-338.
17. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-1350.
18. Law J., Haandrikman A. Proteolytic enzymes of lactic acid bacteria. Int. Dairy J. 1997, 7:1-11.
19. LeBlanc J.G., Matar C., Valdéz J.C., LeBlanc J., Perdigon G. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 2002, 85:2733-2742.
20. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
21. Matar C., Valdez J.C., Medina M., Rachid M., Perdigon G. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res. 2001, 68:601-609.
22. Rath H.C., Wilson K.H., Sartor R.B. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect. Immun. 1999, 67:2969-2974.
23. Rhee C.H., Park H.D. Three glycoproteins with antimutagenic activity identified in Lactobacillus plantarum KLAB21. Appl. Environ. Microbiol. 2001, 67:3445-3449.
24. Sadat-Mekmene L., Genay M., Atlan D., Lortal S., Gagnaire V. Original features of cell-envelope proteinases of Lactobacillus helveticus. A review. Int. J. Food Microbiol. 2011, 146:1-13.
25. Sainte-Marie G. A paraffin embedding technique for studies employing immunofluorescence. J. Histochem. Cytochem. 1962, 10:250-256.
26. Saito J., Sakai Y., Nagase H. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens. Mutat. Res. 2006, 609:68-73.
27. Sandré C., Gleizes A., Forestier F., Gorges-Kergot R., Chilmonczyk S., Leonil J., Moreau M.-C., Labarre C. A peptide derived from bovine β-casein modulates functional properties of bone marrow-derived macrophages from germfree and human flora-associated mice. J. Nutr. 2001, 131:2936-2942.
28. Silva S.V., Malcata F.X. Caseins as source of bioactive peptides. Int. Dairy J. 2005, 15:1-15.
29. Strober W., Fuss I., Boirivant M., Kitani A. Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammation. Ann. N. Y. Acad. Sci. 2004, 1029:115-131.
30. Strober W., Fuss I., Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007, 117:514-521.
31. te Velde A.A., Verstege M.I., Hommes D.W. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm. Bowel Dis. 2006, 12:995-999.
32. Tellez A., Corredig M., Brovko L.Y., Griffiths M.W. Characterization of immune-active peptides obtained from milk fermented by Lactobacillus helveticus. J. Dairy Res. 2010, 77:129-136.
33. Thomas T.D., Mills O.E. Proteolytic enzymes of starter bacteria. Neth. Milk Dairy J. 1981, 35:255-273.
34. Verdù E.F., Bercik P., Cukrowska B., Farre-Castany M.A., Bouzourene H., Saraga E., Blum A.L., Corthésy-Theulaz I., Tlaskalova-Hogenova H., Michetti P. Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice. Clin. Exp. Immunol. 2000, 120:46-50.
35. Wirtz S., Neufert C., Weigmann B., Neurath M.F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007, 2:541-546.